Fate Therapeutics (FATE) Long-Term Debt Repayments (2013 - 2019)

Fate Therapeutics (FATE) has 6 years of Long-Term Debt Repayments data on file, last reported at $14.0 million in Q4 2019.

• Quarterly Long-Term Debt Repayments changed N/A year-over-year to $14.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $22.7 million (changed N/A YoY) and the FY2019 annual result came in at $15.0 million, changed N/A from the prior year.
• Long-Term Debt Repayments improved to $14.0 million in Q4 2019, from $6.7 million in the prior quarter.
• In the past five years, Long-Term Debt Repayments ranged from a high of $14.0 million in Q4 2019 to a low of $600000.0 in Q3 2015.
• A 4-year average of $3.4 million and a median of $1.9 million in 2016 frame the typical range for Long-Term Debt Repayments.
• Annual changes were most pronounced in 2015 — Long-Term Debt Repayments declined 20.0% — and 2017, when it jumped 253.11%.
• Tracing FATE's Long-Term Debt Repayments over 4 years: stood at $935000.0 in 2015, then surged by 111.23% to $2.0 million in 2016, then jumped by 239.7% to $6.7 million in 2017, then surged by 108.67% to $14.0 million in 2019.
• The last three Long-Term Debt Repayments figures came in at $14.0 million (Q4 2019), $6.7 million (Q3 2017), and $2.0 million (Q2 2017), per Business Quant data.